Show simple item record

AuthorAl Zoubi, Mazhar Salim
AuthorAl Kreasha, Rasha
AuthorAqel, Sarah
AuthorSaeed, Ahmad
AuthorAl-Qudimat, Ahmad R.
AuthorAl-Zoubi, Raed M.
Available date2024-05-09T08:04:34Z
Publication Date2024-02-21
Publication NameIrish Journal of Medical Science
Identifierhttp://dx.doi.org/10.1007/s11845-024-03634-4
CitationAl Zoubi, M. S., Al Kreasha, R., Aqel, S., Saeed, A., Al-Qudimat, A. R., & Al-Zoubi, R. M. (2024). Vitamin B12 deficiency in diabetic patients treated with metformin: A narrative review. Irish Journal of Medical Science (1971-), 1-9.
ISSN0021-1265
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85185526998&origin=inward
URIhttp://hdl.handle.net/10576/54788
AbstractMetformin is the most prescribed oral hypoglycemic drug and is considered by many health practitioners as the first-line treatment for non-insulin-dependent diabetes mellitus (T2DM). It is used either as a monotherapy or adjuvant to other anti-hyperglycemic agents. Most of its side effects are usually mild and self-limiting. However, several studies have shown an association between the use of metformin and low vitamin B12 levels in diabetic patients. The current review aimed to provide a literature review of the current published reports on the association, the possible mechanisms, and the related individualized risk factors that might lead to this incidence. The most accepted mechanism of the effect of metformin on vitamin B12 level is related to the absorption process where metformin antagonism of the calcium cation and interference with the calcium-dependent IF-vitamin B12 complex binding to the ileal cubilin receptor. In addition, many risk factors have been associated with the impact of metformin on vitamin B12 levels in diabetic patients such as dose and duration where longer durations showed a greater prevalence of developing vitamin B12 deficiency. Male patients showed lower levels of vitamin B12 compared to females. Black race showed a lower prevalence of vitamin B12 deficiency in metformin-treated patients. Moreover, chronic diseases including T2DM, hyperlipidemia, coronary artery disease, polycystic ovary disease (PCOD), obesity, and metformin therapy were significantly associated with increased risk of vitamin B12 deficiency. Graphical abstract: Metformin impacts vitamin B12 by (A) inhibiting calcium-dependent IF-B12 binding. (B) Prolonged use raises deficiency risk. (C) Males have lower B12 levels than females. (D) Black individuals show lower deficiency rates. (E) Conditions like T2DM, hyperlipidemia, coronary artery disease, PCOD, obesity, and metformin use heighten deficiency risk. (Figure presented.).
SponsorOpen Access funding provided by the Qatar National Library.
Languageen
SubjectB12 deficiency
Diabetes mellitus
Metformin
T2DM
TitleVitamin B12 deficiency in diabetic patients treated with metformin: A narrative review
TypeArticle
Pagination1-9
ESSN1863-4362
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record